Clinical Trial Update: A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

View source ↗

Summary

A clinical trial evaluating the enVista Aspire intraocular lens in patients undergoing cataract extraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• enVista Aspire intraocular lens (intraocular lens)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract | Status: COMPLETED